AIMCA
JSPR icon

Alberta Investment Management Corp (AIMCo)’s Jasper Therapeutics JSPR Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,000
Closed -$2.1M – 868
2020
Q4 		$2.1M Sell
21,000
-7,000
-25% -$697K 0.02% 512
2020
Q3 		$2.79M Hold
28,000
– – 0.03% 460
2020
Q2 		$2.87M Hold
28,000
– – 0.03% 438
2020
Q1 		$2.67M Buy
+28,000
New +$2.74M 0.05% 379

Other funds holding JSPR

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $879M AUM 29.99% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s JSPR Position: Q1 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Jasper Therapeutics (JSPR) in Q1 2021, closing a stake of 21,000 shares — an estimated $2.1M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in JSPR in Q1 2020 and held it in 4 quarters. The position peaked at $2.87M in Q2 2020. 53 funds tracked by Wall St. Rank hold JSPR as of Q1 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Jasper Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 21,000 Jasper Therapeutics shares in Q1 2021, an estimated $2.1M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Jasper Therapeutics in Q1 2020 and held it in 4 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Jasper Therapeutics position peaked at $2.87M in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2021, filed 7 May 2021.